AIDS/HIV infection and cerebrovascular disease

Seminars in Cerebrovascular Diseases and Stroke

Volumn 5, Issue 1, 2005, Pages 40-46

  Nogueira Pinto, Amélia ^a  

^a HOSPITAL FERNANDO FONSECA   (Portugal)

Author keywords

Acquired immunodeficiency syndrome; Cerebrovascular disease; HAART therapy; HIV infection

Indexed keywords

ANTIRETROVIRUS AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ENDOCARDITIS; FREQUENCY ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; LIPODYSTROPHY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; SURVIVAL RATE; THROMBOCYTOSIS; VASCULAR DISEASE;

EID: 28844436408     PISSN: 15289931     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.scds.2005.04.015     Document Type: Article

References (67)

1. R.W. Price Neurological complications of HIV infection Lancet 348 1996 445-452
2. A.N. Pinto Aids and cerebrovascular disease Stroke 27 1996 538-543
3. A. Rabinstein Stroke in HIV-infected patients: A clinical perspective Cerebrovasc Dis 15 2003 37-44
4. H.R. Brodt B.S. Kamps P. Gute et al. Changing incidence of AIDS-defining illness in the era of antiretroviral combination therapy AIDS 11 1997 1731-1737
5. N.C. Sacktor R.H. Lyles R. Skolasky et al. HIV-associated neurological disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998 Neurology 56 2 2001 257-260
6. W.D. Snider D.M. Simpson S. Nielsen et al. Neurological complications of the acquired immunodeficiency syndrome: Analysis of 50 patients Ann Neurol 14 1983 403-418
7. B.S. Koppell G.P. Wormser A.J. Tuchman et al. Central nervous system involvement in patients with the acquired immunodeficiency syndrome (AIDS) Acta Neurol Scand 71 1985 337-353
8. R.M. Levy D.E. Bredensen M.L. Rosenblum Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience of UCSF and review of the literature J Neurosurg 62 1985 475-495
9. J.R. Berger L. Moskowitz M. Fischl et al. Neurological disease as the presenting manifestation of acquired immunodeficiency syndrome South Med J 80 1987 683-686
10. J.C. McArthur Neurological manifestations of AIDS Medicine 66 1987 407-437
11. R.M. Levy D.E. Bredensen CNS dysfunction in AIDS J Acquir Immune Defic Syndr 1 1988 41-64
12. J.W. Engstrom D.H. Lowenstein D.E. Bredensen Cerebral infarctions and transient neurological deficits associated with acquired immunodeficiency syndrome Am J Med 86 1989 528-532
13. D.M. Keeling H. Birley S.J. Machin Multiple transient ischemic attacks in a HIV-positive patient with anticardiolipine antibodies Blood Coag Fibrinol 1 1990 333-335
14. I. Casado-Naranjo J.A. Toledo-Santos M.A. Antolin-Rodriguez Ischemic stroke as the sole manifestation of HIV infection Stroke 23 1992 117-118
15. J. Atalaia J.M. Ferro F. Antunes Stroke in an HIV-infected patient J Neurol 239 1992 356-357
16. K.D. Kieburtz T.A. Eskin L. Ketonen et al. Opportunistic cerebral vasculopathy and stroke in patients with the acquired immunodeficiency syndrome Arch Neurol 50 1993 430-432
17. S. Thirumalai H.S. Kirshner Anticardiolipin antibody and stroke on an HIV-positive patient AIDS 8 1994 1019-1020
18. G.G. Baily B.K. Mandal Recurrent transient neurological deficits in advanced HIV infection AIDS 9 1995 709-712
19. M. Strobel I. Lamaury F. Brouzes et al. Accidents vasculaires cérébraux et sida Rev Med Interne 16 1995 743-746
20. P. Zunker D.G. Nabavi A. Allardt HIV-associated stroke: Report of two unusual cases Stroke 27 1996 1694-1696
21. A.I. Qureshi R.S. Janssen J.M. Karon et al. Human immunodeficiency virus infection and stroke in young patients Arch Neurol 54 1997 1150-1153
22. A.R. Gillams E. Allen K. Hrieb et al. Cerebral infarction in patients with AIDS Am J Neuroradiol 18 1997 1581-1585
23. J. Roquer E. Palomeras H. Knobel et al. Intracerebral haemorrhage in AIDS Cerebrovasc Dis 8 1998 222-227
24. J. Berkefeld W. Enzensberger H. Lanfermann MRI in human immunodeficiency virus-associated cerebral vasculitis Neuroradiology 42 2000 526-528
25. M. Hoffmann J.R. Berger A. Nath et al. Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa J Neurovirol 6 2000 229-236
26. T. Menge T. Neumann-Haefelin H.J. von Giesen et al. Progressive stroke in an HIV-1-positive patient under protease inhibitors Eur Neurol 44 2000 252-254
27. A. Mocham M. Modi G. Modi Stroke in black South Africans HIV-positive patients. A prospective study. Stroke 34 2003 10-15
28. S. Evers D. Nabavi A. Rahmann et al. Ischemic cerebrovascular events in HIV infection Cerebrovasc Dis 15 2003 199-205
29. J.W. Cole A.N. Pinto R. Hebel et al. Acquired immunodeficiency syndrome and the risk of stroke Stroke 35 2004 51-56
30. Human immunodeficiency virus (HIV) infection codes. official authorized addendum. ICD-9-CM (Revision No. 1) effective January 1988 MMRW Morb Mortal Wkly Rep 36 1987 1S-20S
31. A.B. Grindal R.J. Cohen R.F. Saul et al. Cerebral infarction in young adults Stroke 9 1978 39-42
32. S. Blecic J. Bogousslavsky Stroke in young adults in H.J.M. Barnett J. Mohr B.M. Stein F.M. Yatsu (eds.) Stroke. Pathophysiology, Diagnosis, and Management 1998 Churchill-Livingstone New York 1001-1012
33. K. Berger H. Schulte F. Stogbauer et al. Incidence and risk factors for stroke in an occupational cohort: The PROCAM study Stroke 29 1998 1562-1566
34. G. Barbaro Highly active retroviral therapy and the cardiovascular system: The heart of the matter Pharmacology 69 2003 177-179
35. C.M. Reichert T.J. O'Leary D.L. Levens et al. Autopsy pathology in the acquired immune deficiency syndrome Am J Pathol 112 1983 357-382
36. L.A. Guarda M.A. Luna L. Smith et al. Acquired immunodeficiency syndrome: Postmortem finding Am J Clin Pathol 81 1984 549-557
37. L.B. Moskowitz G.T. Hensley J.C. Chan et al. The neuropathology of acquired immunodeficiency syndrome Arch Pathol Lab Med 108 1984 867-872
38. L.R. Sharer R. Kapila Neuropathologic observations in the acquired immunodeficiency syndrome (AIDS) Acta Neuropathol (Berl) 66 1985 188-198
39. K.H. Anders W.F. Guerra Tomiyasu et al. The neuropathology of AIDS Am J Pathol 124 1986 537-558
40. H. Budka G. Costanzi S. Cristina et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV): A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases Acta Neuropathol (Berl) 75 1987 185-198
41. E.S. Cho L.R. Sharer N.S. Peress et al. Intimal proliferation of leptomeningeal arteries and brain infarcts in subjects with AIDS J Neuropathol Exp Neurol 46 1987 385
42. H. Mizusawa A. Hirano J.F. Llena et al. Cerebrovascular lesions of AIDS Acta Neuropathol (Berl) 76 1988 451-457
43. P.L. Lantos J.E. McLaughlin C.L. Scholtz et al. Neuropathology of the brain in HIV infection Lancet 333 1989 309-310
44. J.R. Berger J.O. Harris J. Gregorios et al. Cerebrovascular disease in AIDS: A case-control study AIDS 4 1990 239-244
45. M.D. Connor G.A. Lammie J.E. Bell et al. Cerebral infarction in adult AIDS patients. Observation from the Edinburgh HIV autopsy cohort. Stroke 31 2000 2117-2126
46. M.W. Saif B. Greenberg HIV and thrombosis: A review AIDS Patient Care STDS 15 2001 15-24
47. L.R. Caplan Nonatherosclerosis vasculophaties. A Clinical Approach in L.R. Caplan (ed) Caplan's Stroke 2000 Butterworth-Heinemann Boston pp. 321-322
48. C. Nogueras M. Sala M. Sasal et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with HIV Arch Neurol 59 2002 468-473
49. Y.R. Tran Dinh H. Mamo J. Cervoni Disturbances in the cerebral perfusion of HIV-1 seropositive asymptomatic subjects: A quantitative tomography study of 18 cases J Nucl Med 31 1990 1601-1607
50. R. Brilla D.G. Nabavi G. Schulte-Altedorneburg Cerebral vasculopathy in HIV infection revealed by transcranial Doppler: A pilot study Stroke 30 1999 811-813
51. J.D. Passaralis K.A. Sepkowitz M.J. Glesby Coronary artery disease and human immunodeficiency virus infection Clin Infect Dis 31 2000 787-797
52. A. Lafeuillade M.C. Alessi I. Poizot-Martins et al. Endothelial cell dysfunction in HIV infection J Acquir Immune Defic Syndr 5 1992 127-131
53. A. Blann J. Constans F. Dignat-George et al. The platelet and endothelium in HIV infection Br J Haematol 100 1998 613-614
54. J.H. Stein M.A. Klein J.L. Bellehumeur et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelium dysfunction Circulation 104 2001 257-262
55. K. Henry H. Melroe J. Heubesch et al. Severe premature coronary artery disease with protease inhibitors Lancet 351 1998 1328
56. G. Behrens H. Schmidt D. Meyer et al. Vascular complications associated with the use of HIV protease inhibitors Lancet 351 1998 1958
57. D. Vittecoq L. Escaut J.J. Monsuez Vascular complications associated with the use of HIV protease inhibitors Lancet 351 1998 1958-1959
58. J. Laurence Vascular complications associated with the use of HIV protease inhibitors Lancet 351 1998 1960
59. A. Carr K. Samarras S. Burton et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 F51-F58
60. S. Tsiodras C. Mantzoros S. Hammer Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study Arch Intern Med 160 2000 2050-2056
61. G. Barbaro Cardiovascular manifestation of HIV infection Circulation 106 2002 1420-1425
62. S.D. Holmberg A.C. Moorman J.M. Williamson et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1 Lancet 360 2002 1747-1748
63. S.A. Bozette C.F. Ake H.K. Tam et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection N Engl J Med 348 2003 702-710
64. N.M. Graham Metabolic disorders among HIV-infected patients treated with protease inhibitors: A review AIDS 5 2000 S4-S11
65. D. Periard A. Telenti P. Sudre et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors Circulation 100 1999 700-705
66. C. Hadigan J.B. Meigs J. Rabe et al. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance J Clin Endocrinol Metab 86 2001 939-943
67. M.J. Miguez-Burbano X. Burbano A. Rodriguez et al. Development of thrombocytosis in HIV+ drug users Impact of retroviral therapy. Platelets 13 2002 183-185